Nicotinamide Mononucleotide (NMN): Difference between revisions

Nicotinamide Mononucleotide (NMN) (view source)

577 bytes added , 2 December 2023

2,851

edits

@@ Line 340: / Line 340: @@
 |-
 |{{pmid text|36443648}}
+|6 weeks, lifestyle modifications
+* no NMN (n=10)
+* 800 mg/day (n=9)
 |
+* 19 mild hypertensive adults
+* age 18-80
 |
-|
+* Supplementing hypertension patients with 800 mg of oral NMN per day for six weeks significantly lowers their blood pressure.
+* Hypertension patients display significantly lower blood cell NAD+ levels, and taking NMN increases their blood cell NAD+ levels by ~43%..
+* Adults with hypertension have cells lining blood vessels — endothelial cells — with elevated concentrations of the NAD+ consuming enzyme CD38, which partially explains their lower NAD+ levels.
 |}